XML 56 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Revenue Recognition (Details) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Jun. 30, 2013
Olympus and Olympus-Cytori [Member]
Sep. 30, 2012
BARDA Contract [Member]
Jun. 30, 2013
BARDA Contract [Member]
Jun. 30, 2013
Revenue Recognized [Member]
Customer
Jun. 30, 2012
Revenue Recognized [Member]
Customer
Jun. 30, 2013
Credit Concentration Risk [Member]
Customer
Jun. 30, 2012
Credit Concentration Risk [Member]
Customer
Jun. 30, 2013
North America [Member]
Jun. 30, 2012
North America [Member]
Jun. 30, 2013
Japan [Member]
Jun. 30, 2012
Japan [Member]
Jun. 30, 2013
Europe [Member]
Jun. 30, 2012
Europe [Member]
Jun. 30, 2013
Other countries [Member]
Jun. 30, 2012
Other countries [Member]
Revenue Recognition [Abstract]                                        
Period of services provided subsequent to date of sale     1 year                                  
Revenues from External Customers and Long-Lived Assets [Line Items]                                        
Number of customers                 2 1 2 3                
Product revenues $ 1,408,000 $ 1,947,000 $ 2,800,000 $ 3,427,000                 $ 583,000 $ 487,000 $ 1,487,000 $ 1,749,000 $ 625,000 $ 619,000 $ 105,000 $ 572,000
Concentration risk percentage (in hundredths)     100.00% 100.00%         38.00% 21.00% 58.00% 52.00% 21.00% 14.00% 53.00% 51.00% 22.00% 18.00% 4.00% 17.00%
Research and Development Arrangements [Line Items]                                        
Deferred revenues, related party 0   0   638,000 28,311,000                            
Deferred revenue, related party, revenue recognized 638,000 2,413,000   2,413,000                                
Costs associated with the development device 4,150,000 3,224,000 7,869,000 6,060,000     106,000,000                          
Research and development arrangement with federal government, customer funding to offset costs incurred               $ 4,700,000                        
Research and development arrangement, initial base period               2 years